Fingolimod

Trade Name: 
Gilenya
Manufacturer/Distributor: 
Novartis
(514) 631-6775 www.novartis.ca
Classification: 
Sphingosine 1-phosphate receptor modulator
ATC Class: 
L04AA27 - Fingolimod
Status: 
active
Notice of Compliance (yyyy/mm/dd): 
2011/03/09
Date Marketed in Canada (yyyy/mm/dd): 
2011/04/04
Presentation: 
Capsules: 0.5 mg
Comments: 
Indicated as monotherapy for relapsing-remitting multiple sclerosis, to reduce the frequency of clinical exacerbations and to delay the progression of the physical disability.